Analisi economica dei costi e dei benefici dell’implementazione di un programma di prevenzione antirotavirus con il vaccino pentavalente in Italia

Background The economic burden of rotavirus gastroenteritis (RVGE) to society is high as shown from results of recent European studies. The evidence suggests that the implementation of antirotavirus vaccination programs can substantially decrease costs, thus freeing resources for alternative uses. The objective of this study was to measure the health benefits and costs of a pentavalent vaccination program in Italy.